Matt D'Auria

Sales & Marketing

Matt D’Auria is a talent-centric leader who has been building and leading medical communications teams for over 20 years.

News

Zymeworks has reached a deal to buy Theravance, claiming rights to COPD therapy Yupelri, sold by Viatris, which made $267m last year.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.